What is TetraScience?
TetraScience operates as the R&D Data Cloud company, dedicated to revolutionizing life sciences research by accelerating discovery and improving human health. Its platform provides life sciences organizations with the essential flexibility, scalability, and data-centric capabilities required for centralized, harmonized, and actionable scientific data. The Tetra R&D Data Cloud is actively deployed across major enterprise pharmaceutical and biotechnology firms. As an open platform, TetraScience has cultivated an extensive integration network, encompassing laboratory instruments, informatics applications, CRO/CDMOs, analytics, and data science partners. This expansive ecosystem fosters seamless interoperability and creates a vital innovation feedback loop, poised to shape the future of R&D in the life sciences industry.
How much funding has TetraScience raised?
TetraScience has raised a total of $103M across 3 funding rounds:
Series A
$8M
Series B
$80M
Private Equity
$15M
Series A (2019): $8M with participation from Floodgate Capital, Underscore VC, Waters, First Round Capital, Y Combinator, and Founder Collective
Series B (2021): $80M led by Alkeon Capital Management and Insight Partners
Private Equity (2026): $15M, investors not publicly disclosed
Key Investors in TetraScience
Alkeon Capital Management
Alkeon Capital Management is a global investment firm that focuses on technology and growth-stage companies. They are known for their strategic investments in companies that demonstrate significant potential for disruption and market leadership.
Insight Partners
Insight Partners is a leading global venture capital and private equity firm specializing in high-growth technology and software companies. They provide strategic guidance and operational support to help their portfolio companies scale effectively.
Floodgate Capital
Floodgate Fund is a venture capital firm that specializes in early stage investments in technology companies. The firm aims to support extraordinary founders at the pre-seed and seed stages, focusing on innovative companies that are considered pattern breakers in the tech industry.
What's next for TetraScience?
With the recent strategic investment, TetraScience is well-positioned to further enhance its R&D Data Cloud capabilities and expand its integration network. The company's focus on providing a scalable, data-centric platform for the life sciences industry aligns with the growing demand for efficient data management and analysis in drug discovery and development. Future growth is likely to involve deepening partnerships with key players in the pharmaceutical and biotech sectors, as well as continuing to innovate its platform to address emerging challenges in scientific data interoperability. The company's strategy appears geared towards solidifying its market leadership and driving further advancements in life sciences R&D.
See full TetraScience company page
